- Home
- AORT vs DX Comparison
AORT vs DX Comparison
Compare AORT & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AORT
- DX
- Stock Information
- Founded
- AORT 1984
- DX 1987
- Country
- AORT United States
- DX United States
- Employees
- AORT N/A
- DX N/A
- Industry
- AORT Medical/Dental Instruments
- DX Real Estate Investment Trusts
- Sector
- AORT Health Care
- DX Real Estate
- Exchange
- AORT Nasdaq
- DX Nasdaq
- Market Cap
- AORT 1.4B
- DX 1.3B
- IPO Year
- AORT 1993
- DX N/A
- Fundamental
- Price
- AORT $31.66
- DX $12.76
- Analyst Decision
- AORT Strong Buy
- DX Buy
- Analyst Count
- AORT 5
- DX 5
- Target Price
- AORT $32.40
- DX $12.67
- AVG Volume (30 Days)
- AORT 349.3K
- DX 3.9M
- Earning Date
- AORT 08-07-2025
- DX 07-21-2025
- Dividend Yield
- AORT N/A
- DX 16.00%
- EPS Growth
- AORT N/A
- DX N/A
- EPS
- AORT N/A
- DX 0.79
- Revenue
- AORT $390,084,000.00
- DX $108,019,000.00
- Revenue This Year
- AORT $12.18
- DX N/A
- Revenue Next Year
- AORT $10.39
- DX $23.37
- P/E Ratio
- AORT N/A
- DX $16.10
- Revenue Growth
- AORT 5.94
- DX N/A
- 52 Week Low
- AORT $21.97
- DX $10.79
- 52 Week High
- AORT $32.94
- DX $14.52
- Technical
- Relative Strength Index (RSI)
- AORT 62.03
- DX 62.59
- Support Level
- AORT $30.06
- DX $12.02
- Resistance Level
- AORT $32.94
- DX $12.92
- Average True Range (ATR)
- AORT 0.79
- DX 0.20
- MACD
- AORT 0.06
- DX 0.07
- Stochastic Oscillator
- AORT 61.37
- DX 85.04
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
About DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.